Clinical Trials Logo

Clinical Trial Summary

The intention of this trial is to investigate whether combined Graded Motor Imagery (GMI) and Desensitization (D) among patients with CRPS is clinically more effective than only D and to study changes in connectivity in the Default Mode Network before and after treatment.


Clinical Trial Description

CRPS: Complex regional pain syndrome (CRPS) is characterized by severe and disabling pain typically in a limb in combination with sensory, autonomic, trophic, and motor abnormalities like tremor and dystonia. A distinction is made between CRPS-1, usually following an injury (fracture, surgery) without a nerve lesion, and CRPS-2, in which a distinct nerve lesion can be identified. Brain mapping studies have provided increasing evidence that the central nervous system is playing an important role in the pathogenesis of CRPS. Reorganization of the somatosensory cortex and motor networks, with altered central processing of tactile and nociceptive stimuli as well as movement control has been demonstrated. Functional brain imaging studies suggest that the volume of brain activation differs between motor execution and motor imagery, but the distribution of cerebral activity tends to be similar. Under imaginary movement of affected hands Gieteling et al. (2008) observed that there was reduced activation ipsilaterally in the premotor and adjacent prefrontal cortex, frontal operculum, anterior part of the insula cortex, and the superior temporal gyrus. Stimulus-driven, functional magnetic resonance imaging, however, are time-consuming and prone to possible confounds, especially in clinical populations. In that perspective resting-state functional magnetic resonance imaging (RS-fMRI), measuring the cerebral networks at rest (in absence of any task), is probably better suited to clinical examinations and is widely used to investigate brain networks that exhibit correlated fluctuations. During recent years, a large number of studies have indicated that RS-fMRI is sufficiently constrained by anatomy to allow the architecture of distinct brain systems to be characterized. The default mode network (DMN) is probably the most studied resting state network. It seems to be involved in several processes and is found negatively modulated by chronic pain. Only one published study has investigated cerebral networks and cerebral connectivity in CRPS. Here the default mode network displayed reduced connectivity with the S1 compared to healthy controls. This indicates that decreased connectivity may be a key feature in cerebral functioning of CRPS patients. No study, however, has so far investigated if the reduced connectivity in the DMN is reversed in CRPS patients who experience pain reduction after GMI or desensitization treatment. Diffusion tensor imaging (DTI) is another magnetic resonance technique useful for revealing microstructural properties of tissue, particularly in cerebral white matter. Chronic pain has also been associated with reduced cognitive functioning. If this is caused by pain processing demands, competing with working memory and executive functions, the investigators would expect the cognitive capacity to be improved or restored if the pain is successfully treated. Graded Motor Imagery: Graded Motor Imagery (GMI) is a rehabilitation process and has been used to treat chronic pain conditions and movement problems related to alterations in the nervous system such as CRPS, postamputation limb pain, and back pain. The patients are trained in monitored steps which increase in difficulty as progress is made. The three treatment components include left/right discrimination training, motor imagery exercises and mirror observations of the unaffected limb, appearing as the affected limb. The components are performed sequentially, but require a flexible approach to suit the individual patient. The imagined movements have been demonstrated to activate motor cortical areas similar to those activated in the actual execution of that movement. Desensitization: Tactile desensitization (D) is used to decrease hyperalgesia and allodynia by repeatedly touching the affected area with various materials. This has successfully been used clinically in the treatment of CRPS. Hypotheses: The following hypotheses will be investigated: 1. Patients, treated with GMI + D, experience a larger pain reduction compared with those subjected to D only. 2. Non-responders to D alone experience pain reduction when D is combined with GMI. 3. Patients with CRPS display reduced intra-network connectivity in the DMN compared to healthy controls. 4. Reduced intra-network connectivity in CRPS is associated with pain intensity. 5. Reduced connectivity in the DMN is reversed in patients who experience pain reduction after GMI and D treatment. This will be evident in the comparison of fMRI data obtained before and after treatment. 6. Microstructure of the cerebral white matter is changed during the intervention. Design:The effects of treatment with Graded Motor Imagery (GMI ) and D versus D alone will be compared with an open, randomized, semi-cross-over case-control design. The study patients will be allocated to either GMI+D or D alone. After an initial treatment period of six weeks responders (R) stay in the same treatment group and continue this treatment. Non-responders (NR) in the D treatment group will be offered an immediate combined treatment (GMI+D). Randomization: The recruited patients will be allocated in a ratio 1:1 by randomization with a fixed block size of 6. Analytical models: Self reported symptom burden and functional capacity will be compared between the two treatment groups and within each treatment group (i.e. comparisons before and after treatment and with each patient as his/her own control). The investigators will also compare the two intervention groups (CRPS patients receiving a GMI+D and D alone) with a non-randomized comparison group of sex- and age-matched healthy persons. Continuous, symmetrically distributed variables will be expressed by mean values with 95% confidence intervals (95% CI) constructed by the Student procedure. Proportions will be presented using the Binomial model with the exact 95% calculated confidence interval. Assumed continuously distributed variables will be analyzed by Analysis of Variance (ANOVA) model with the initial value as covariate while contingency table analysis is used for group comparisons of categorical and ranked variables. The sample size calculation is based on distribution of the main variable, self-rated limb pain measured by Visual Analogue scaling (VAS). Based on the assumption of normality, a significance level of 5 % (α = 0.05), a power of (β = 0.80) and a clinical relevant difference of one time Standard Deviation (SD), 21 patients should be included in each of the two treatment groups. There will also be a sex- and age-matched comparison group of healthy persons (n:21). Interventions: Individually adjusted Graded motor imagery (GMI) and tactile desensitization (D). Measurements: MRI-scanning (for analyses of Intra-network connectivity in the DMN and DTI for microstructural changes in the white matter), Quantitative Sensory Testing (QST) and Neuropsychological tests are performed before the randomization and 12 months later. Self reporting questionnaires will be performed at baseline, after the treatment period of six weeks, and at the 6 and 12 month follow up. This includes demographic variables, and a comorbidity check list of diseases related to the major organ systems, pain intensity measured by numerical scales for pain intensity and by Visual Analogue Scale (VAS), consumption of analgesics and the questionnaires: CRPS Severity Score, if upper limb affected; Quick DASH (a short form of Disabilities of the Arm, Shoulder and Hand Outcome Measure), if lower limb affected; Lower extremity functional scale, Impact of Event Scale-6 if subjected to adverse life events, Insomnia Severity Index, The Hopkins Symptoms Checklist (HSCL- 25), Pain Catastrophizing Scale, Perceived self efficacy and the Bath CRPS Body Perception Disturbance Scale ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02753335
Study type Interventional
Source University of Tromso
Contact Gunnvald Kvarstein, PhD
Email gunnvald.kvarstein@uit.no
Status Recruiting
Phase N/A
Start date September 2016
Completion date December 2024

See also
  Status Clinical Trial Phase
Recruiting NCT01134289 - Analysis of Photoplethysmographic Signal in Lumbar Sympathetic Block Phase 3
Completed NCT00579085 - Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS Phase 2
Completed NCT02837822 - Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients N/A
Completed NCT02070367 - Somatosensory Assessment and Rehabilitation of Allodynia (SARA) N/A
Completed NCT00462566 - The Efficacy of Motor Cortex Stimulation for Pain Control N/A
Active, not recruiting NCT03228160 - Light Irradiation and Outcome for Neuropathic Pain N/A
Terminated NCT02094352 - Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome Phase 2
Recruiting NCT06306157 - Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome Phase 4
Recruiting NCT02502162 - Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome N/A
Recruiting NCT06393101 - The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome Phase 1
Completed NCT03990649 - Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS) Phase 2
Recruiting NCT03616262 - "Efficacy of Botulinum Toxin Injection in Reducing Limb Pain in Patients With Complex Regional Pain Syndrome" Early Phase 1
Active, not recruiting NCT02504008 - CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1 Phase 3
Completed NCT03879538 - Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome Phase 3
Terminated NCT03794024 - Comparison of Dorsal Column Stimulation to Dorsal Root Ganglion Stimulation for Complex Regional Pain Syndrome
Terminated NCT00780390 - Autonomic Dysfunction and Spinal Cord Stimulation in Complex Regional Pain Syndrome N/A
Completed NCT00904202 - A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Phase 4
Recruiting NCT05197959 - Treatment of Complex Regional Pain Syndrome N/A
Completed NCT02753101 - [18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica Early Phase 1
Withdrawn NCT00414804 - Spinal Cord Stimulation Versus Nerve Blocks and Physical Therapy N/A